Нилотиниб Виатрис

Nilotinib Viatris is an oral cancer treatment medication used to manage certain types of leukemia. This prescription therapy targets specific proteins to help control disease progression. Always use as directed by a healthcare professional. Store in a cool, dry place away from direct sunlight.

Nilotinib is prescribed for adults with chronic myeloid leukemia (CML) in chronic or accelerated phases. It is also used to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) when standard treatments are not suitable. This medication helps slow the growth of cancer cells by targeting specific enzymes involved in cell signaling. Patients may use it as part of long-term therapy to maintain disease control.

Common effects may include mild nausea, headache, or fatigue. Some users report temporary changes in appetite or mild digestive discomfort. These effects are typically temporary and vary between individuals. Regular monitoring by a healthcare provider helps manage any persistent issues.

Keep this medication out of reach of children and pets. Store at room temperature, away from moisture and heat. Do not use if the packaging is damaged or the medication appears discolored. Inform your doctor about all current medications and medical conditions before starting treatment.

Nilotinib may interact with certain foods, herbal supplements, or other medications, including some antibiotics and antifungals. Grapefruit products can affect how the body processes this drug. Avoid alcohol and consult your healthcare provider before combining with other therapies to prevent potential interactions.